-
- Up one level
- 16th Harry Guess Memorial Lecture
Nancy Dreyer, PhD, MPH, FISPE, "Using person-generated health data in pharmacoepidemiology: Power to the People"
Wednesday, April 26, 2023, 136 Tate-Turner-Kuralt and Zoom
- An Epidemiologic View of Causation
Backgrounder by Nancy A. Dreyer on theories of causation, relative risk, statistical significance and, on what epidemiology can and can't tell you, for PBS Frontline, Breast Implants on Trial, January 1994.
- Brandeis University, Board of Trustees biography
Nancy A. Dreyer ’72, Elected May 2019
Nancy Dreyer is chief scientific officer and senior vice president at IQVIA, a global provider of analytics, technology solutions and research services that helps medical providers, pharmaceutical and biotech companies, clinical trial investigators and other clients accelerate product development and improve healthcare.
- DIA Author of the Year Award
Advancing a Framework for Regulatory Use of Real World Evidence: When Real is Reliable
- DIA Fellow and Inspire Award Winner
Drug Information Association (DIA) spotlight
- Dreyer Professorship in Epidemiology
Carolina Public Health Magazine, May 5, 2016
In 2015, Nancy Dreyer established The Nancy A. Dreyer Distinguished Professorship Fund. Distributions from the fund will support an endowed chair to attract or retain a distinguished teacher and scholar in epidemiology.
- ISPOR Summit 2018 - Speaker
- LinkedIn page
- Red Jacket Dr. Nancy A. Dreyer
"Shaping the Future of Real-World Evidence", PharmaVoice newsletter, August 1, 2020
- Registries for Evaluating Patient Outcomes: A User's Guide
Registries for Evaluating Patient Outcomes: A User’s Guide (fourth edition)
Prepared for the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
Contract No. 290-2014-00004-C
Senior Editors: Richard E. Gliklich, M.D., Michelle B. Leavy, M.P.H., Nancy A. Dreyer, Ph.D., M.P.H., FISPE
AHRQ Publication No. 19(20)-EHC020 September 2020
- The Evolving Relationship Between Real World Data and Clinical Trials with Nancy Dreyer and C.K. Wang (33 min.)
In this episode of Real World Talk, host Zoe Li talks to Nancy Dreyer, Chief Scientific Officer of IQVIA, and COTA’s own Chief Medical Officer, Dr. C.K. Wang. They discuss the interactions between real world data and clinical trials, and how the two approaches can complement each other.